|
|
(15 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
Zeile 1: |
Zeile 1: |
| __NOTOC__ | | __NOTOC__ |
| *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
− | *[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187738/?report=classic big link list published as a paper]
| + | |
| + | |
| *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
− | *[https://www.newsweek.com/russia-developing-coronavirus-treatment-that-disinfects-body-uv-light-inside-1508350 uv emitting particles to be inhaled under dev in Russia]
| |
| | | |
| *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
− | {{tp|p=32145323|t=2020. Understanding the emerging coronavirus: what it means for health security and infection prevention |pdf=|usr=}}
| |
− | {{tp|p=32020374|t=2020. The Role of Augmented Intelligence (AI) in Detecting and Preventing the Spread of Novel Coronavirus |pdf=|usr=}}
| |
− | {{tp|p=32282863|t=2020. Molecular immune pathogenesis and diagnosis of COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32458804|t=2020. The immune system of children: the key to understanding SARS-CoV-2 susceptibility?|pdf=|usr=}}
| |
− |
| |
− |
| |
| *'''[[Clinical guidelines and advice]]''' | | *'''[[Clinical guidelines and advice]]''' |
− | {{tp|p=32413768|t=2020. Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients |pdf=|usr=}}
| |
| | | |
| | | |
Zeile 20: |
Zeile 13: |
| | | |
| *'''[[Diagnosis (Laboratory)]]''' | | *'''[[Diagnosis (Laboratory)]]''' |
− | {{tp|p=32006218|t=ä. Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia |pdf=|usr=}}
| |
− |
| |
| | | |
| | | |
| *'''[[Diagnosis (Lung CT, Sonography)]]''' | | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
− | {{tp|p=32189008|t=ä. Lung ultrasound and B-lines quantification inaccuracy: B sure to have the right solution |pdf=|usr=}}
| |
− | {{tp|p=32166346|t=ä. Findings of lung ultrasonography of novel corona virus pneumonia during the 2019?2020 epidemic |pdf=|usr=}}
| |
− | {{tp|p=32283316|t=2020. Early Appearance of Coronavirus Disease 2019 Associated Pulmonary Infiltrates During Daily Radiotherapy Imaging for Lung Cancer |pdf=|usr=}}
| |
− | {{tp|p=32311499|t=2020. Rapid Detection of Asymptomatic Coronavirus Disease 2019 by Computed Tomography Image Guidance for Stereotactic Ablative Radiotherapy |pdf=|usr=}}
| |
− | {{tp|p=32292624|t=2020. Quantitative computed tomography analysis for stratifying the severity of Coronavirus Disease 2019 |pdf=|usr=}}
| |
− | {{tp|p=32387713|t=ä. Coronavirus Disease 2019 or Lung Cancer: A�Differential Diagnostic Experience and Management Model From Wuhan |pdf=|usr=}}
| |
− | {{tp|p=32387580|t=ä. The Use of Positron Emission Tomography in Coronavirus Disease 2019 Cases |pdf=|usr=}}
| |
| | | |
| + | *'''[[Diagnosis (other modalities)]]''' |
| | | |
| | | |
− | *'''[[Diagnosis (other modalities)]]'''
| |
− | {{tp|p=32421627|t=2020. The impact of biosensing in a pandemic outbreak: COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=C7197557|t=ä. Selecting a SARS-CoV-2/COVID molecular testing method for your laboratory |pdf=|usr=}}
| |
− | ----
| |
| | | |
| | | |
| *'''[[Structure of covid19]]''' | | *'''[[Structure of covid19]]''' |
− | {{tp|p=C7181939|t=2020. Etymologia: Coronavirus |pdf=|usr=}}
| |
− | {{tp|p=32387564|t=2020. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2 |pdf=|usr=}}
| |
− | {{tp|p=32387562|t=2020. Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses |pdf=|usr=}}
| |
− | {{tp|p=32092385|t=2020. The continuous evolution and dissemination of 2019 novel human coronavirus |pdf=|usr=}}
| |
− | {{tp|p=32292212|t=2020. Photopolarimetrical properties of coronavirus model particles: Spike proteins number influence |pdf=|usr=}}
| |
− |
| |
| | | |
| | | |
| *'''[[Target binding and uptake]]''' | | *'''[[Target binding and uptake]]''' |
− | {{tp|p=32451080|t=ä. A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization |pdf=|usr=}}
| |
− |
| |
− |
| |
− |
| |
| *'''[[Cytopathic effects]]''' | | *'''[[Cytopathic effects]]''' |
− | {{tp|p=32446559|t=2020. Stability of RNA sequences derived from the coronavirus genome in human cells |pdf=|usr=}}
| |
− |
| |
− |
| |
| *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| | | |
Zeile 66: |
Zeile 34: |
| | | |
| *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
− | {{ttp|p=32073157|t=2020. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus?associated illnesses |pdf=|usr=}}
| |
− | {{tp|p=30715745|t=2019. (+)Th17 serum cytokines in relation to laboratory?confirmed respiratory viral infection: A pilot study |pdf=|usr=}}
| |
− |
| |
| | | |
| *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
− | {{tp|p=32423585|t=2020. Is the HScore useful in COVID-19?|pdf=|usr=}}''index of hyperinflammation''
| + | |
| + | |
| | | |
| *'''[[Pathobiology]]''' | | *'''[[Pathobiology]]''' |
− | {{tp|p=32272221|t=ä. Host proteases as determinants of coronaviral neurotropism and virulence |pdf=|usr=}}
| |
− | {{ttp|p=32243808|t=2020. The Cellular and Physiological Basis for Lung Repair and Regeneration: Past, Present, and Future |pdf=|usr=}}
| |
− | {{tp|p=32375845|t=2020. Acute respiratory failure in COVID-19: is it ?typical? ARDS?|pdf=|usr=}}
| |
− | {{tp|p=32439197|t=ä. COVID-19 and Multiorgan Response |pdf=|usr=}}
| |
− | {{tp|p=32362921|t=2020. Hypoxia in acute cardiac injury of coronavirus disease 2019: lesson learned from pathological studies |pdf=|usr=}}
| |
− | {{tp|p=32340677|t=2020. Pulmonary Pathology of Early Phase 2019 Novel Coronavirus Pneumonia |pdf=|usr=}}
| |
− | {{tp|p=32471641|t=ä. Tubuloreticular inclusions in COVID-19?related collapsing glomerulopathy |pdf=|usr=}}
| |
− | {{tp|p=32471639|t=ä. Collapsing glomerulopathy in a COVID-19 patient |pdf=|usr=}}
| |
− | {{tp|p=32292867|t=2020. Collapsing Glomerulopathy in a Patient With COVID-19 |pdf=|usr=}}
| |
| | | |
| | | |
| *'''[[Disease Models]]''' | | *'''[[Disease Models]]''' |
− | {{tp|p=31583825|t=2019. Improving immunological insights into the ferret model of human viral infectious disease |pdf=|usr=}}
| + | |
− | {{tp|p=15892035|t=2005. An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus |pdf=|usr=}}
| + | |
− | {{tp|p=16501078|t=2006. Modeling the Early Events of Severe Acute Respiratory Syndrome Coronavirus Infection In Vitro |pdf=|usr=}}
| + | |
| | | |
| *'''[[Similar diseases and pathomechanisms]]''' | | *'''[[Similar diseases and pathomechanisms]]''' |
− | {{tp|p=C7130142|t=ä. Tuberculosis and novel Wuhan coronavirus infection: Pathological interrelationship |pdf=|usr=}}
| + | |
− | {{tp|p=32387967|t=2020. A single centre study of viral community-acquired pneumonia in children: No evidence of SARS-CoV-2 from October 2019 to March 2020 |pdf=|usr=}}
| + | |
− | {{ttp|p=17031779|t=2006. Expression of elevated levels of pro?inflammatory cytokines in SARS?CoV?infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS? |pdf=|usr=}}
| + | |
− | {{tp|p=15141376|t=2004. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS?CoV) in SARS patients: implications for pathogenesis and virus transmission pathways |pdf=|usr=}}
| + | |
− | {{tp|p=14743497|t=2004. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in?situ hybridization study of fatal cases |pdf=|usr=}}
| + | |
− | {{tp|p=12845623|t=2003. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China |pdf=|usr=}}
| + | |
− | {{tp|p=32387581|t=ä. EGFR Tyrosine Kinase Inhibitor?Associated Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic |pdf=|usr=}}
| + | |
| | | |
| | | |
Zeile 106: |
Zeile 55: |
| | | |
| *'''[[Co-Infection]]''' | | *'''[[Co-Infection]]''' |
− | {{tp|p=C7195315|t=2020. Co-infections: potentially lethal and unexplored in COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32423586|t=2020. SARS-CoV-2 and influenza virus co-infection |pdf=|usr=}}
| |
− |
| |
| | | |
| | | |
| *'''[[Pulmonary embolism, coagulation]]''' | | *'''[[Pulmonary embolism, coagulation]]''' |
− | {{tp|p=32378044|t=ä. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment |pdf=|usr=}}
| + | |
− | {{ttp|p=32387623|t=ä. Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 |pdf=|usr=}}
| + | |
− | {{tp|p=C7183940|t=ä. Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19 |pdf=|usr=}}
| + | |
− | {{tp|p=32402423|t=2020. Ten key points that vascular doctors learned very quickly about COVID-19 |pdf=|usr=}}
| + | |
− | {{tp|p=32417015|t=ä. Risk of peripheral arterial thrombosis in COVID-19 |pdf=|usr=}}
| + | |
− | {{tp|p=32423583|t=2020. Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19 |pdf=|usr=}}
| + | |
| | | |
| | | |
| | | |
| *'''[[Hematology]]''' | | *'''[[Hematology]]''' |
− | {{tp|p=32284281|t=2020. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019 |pdf=|usr=}}
| |
| | | |
| | | |
− | *'''[[Heart]]'''
| |
− | {{tp|p=32349897|t=2020. Cardiovascular Consequences and Considerations of Coronavirus Infection ? Perspectives for the Cardiothoracic Anesthesiologist and Intensivist During the Coronavirus Crisis |pdf=|usr=}}
| |
− | {{tp|p=32362922|t=2020. Myocardial injury is associated with higher mortality in patients with coronavirus disease 2019: a meta-analysis |pdf=|usr=}}
| |
− | {{tp|p=32362921|t=2020. Hypoxia in acute cardiac injury of coronavirus disease 2019: lesson learned from pathological studies |pdf=|usr=}}
| |
− | {{tp|p=32297133|t=ä. Toward understanding the 2019 Coronavirus and its impact on the heart |pdf=|usr=}}
| |
− | {{tp|p=32292848|t=2020. COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies |pdf=|usr=}}
| |
− | {{tp|p=32292847|t=2020. The Heart in COVID-19: Primary Target or Secondary Bystander?|pdf=|usr=}}
| |
− | {{tp|p=C7195441|t=ä. Prognostic Value of Right Ventricular Longitudinal Strain in Patients with COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=C7142671|t=ä. Spontaneous Coronary Artery Dissection in a Patient with COVID-19 |pdf=|usr=}}
| |
− | {{ttp|p=32386565|t=2020. Hyperinflammatory shock in children during COVID-19 pandemic |pdf=|usr=}}
| |
| | | |
| + | *'''[[Heart]]''' |
| | | |
| | | |
| | | |
| *'''[[Neurology, ophthalmology, orl]]''' | | *'''[[Neurology, ophthalmology, orl]]''' |
− | {{tp|p=32464367|t=2020. The neurology of COVID-19 revisited: ...to implement international neurological registries |pdf=|usr=}}
| |
− | {{tp|p=32413767|t=2020. Myasthenic crisis in COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32422428|t=2020. Venous cerebral thrombosis in COVID-19 patient |pdf=|usr=}}
| |
− | {{tp|p=32387762|t=2020. Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: Case report |pdf=|usr=}}
| |
− | {{tp|p=32389423|t=ä. Acute ischemic stroke complicating common carotid artery thrombosis during a severe COVID-19 infection |pdf=|usr=}}
| |
− | {{tp|p=32355557|t=ä. Ophthalmic manifestations of novel coronaviruses: precautionary measures and diagnostic possibilities |pdf=|usr=}}
| |
− |
| |
| | | |
| | | |
Zeile 155: |
Zeile 80: |
| | | |
| *'''[[Gastroenterology, hepatology]]''' | | *'''[[Gastroenterology, hepatology]]''' |
− | {{tp|p=32096611|t=2020. 2019 Novel coronavirus infection and gastrointestinal tract |pdf=|usr=}}
| |
− | {{tp|p=32387057|t=ä. SARS-CoV-2 infection may result in appendicular syndrome: Chest CT scan before appendectomy |pdf=|usr=}}
| |
| | | |
| *'''[[Kidney, urology]]''' | | *'''[[Kidney, urology]]''' |
− | {{tp|p=32418620|t=ä. Expression of ACE2, the SARS-CoV-2 Receptor, and TMPRSS2 in Prostate Epithelial Cells |pdf=|usr=}}
| |
− | {{tp|p=32471641|t=ä. Tubuloreticular inclusions in COVID-19?related collapsing glomerulopathy |pdf=|usr=}}
| |
− | {{tp|p=32471639|t=ä. Collapsing glomerulopathy in a COVID-19 patient |pdf=|usr=}}
| |
− | {{tp|p=32292867|t=2020. Collapsing Glomerulopathy in a Patient With COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32423587|t=2020. COVID-19-associated nephritis: early warning for disease severity and complications?|pdf=|usr=}}
| |
| | | |
| + | *'''[[The morbid survivor]]''' |
| | | |
| + | *'''[[Risk and special populations]]''' |
| | | |
| | | |
− | *'''[[The morbid survivor]]'''
| |
| | | |
− | *'''[[Risk and special populations]]''' | + | *'''[[Case reports]]''' |
− | {{tp|p=32414646|t=2020. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome |pdf=|usr=}}
| + | |
− | {{tp|p=32371279|t=ä. Therapeutic Strategy for Patients with Coronavirus Disease 2019 During Left Ventricular Assist Device Supports |pdf=|usr=}}
| + | |
− | {{tp|p=32305569|t=2020. Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device Support |pdf=|usr=}}
| + | |
− | {{tp|p=32360010|t=2020. The Renin-Angiotensin-Aldosterone System in Coronavirus Infection-Current Considerations During the Pandemic |pdf=|usr=}}
| + | |
− | {{tp|p=32268149|t=2020. An epidemiological study exploring a possible impact of treatment with ACE inhibitors or angiotensin receptor blockers on ACE2 plasma concentrations |pdf=|usr=}}
| + | |
− | {{tp|p=32408961|t=ä. Clinical course of patients infected with severe acute respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery |pdf=|usr=}}
| + | |
− | {{tp|p=32292915|t=ä. Severe COVID-19 With ARDS in a Patient on Durable LVAD Support |pdf=|usr=}}
| + | |
− | {{tp|p=32380044|t=2020. Obesity could shift severe COVID-19 disease to younger ages |pdf=|usr=}}
| + | |
− | {{tp|p=C7202821|t=2020. COVID-19: underlying metabolic health in the spotlight |pdf=|usr=}}
| + | |
| | | |
| | | |
| | | |
| | | |
− | *'''[[Case reports]]'''
| |
− | {{tp|p=32232784|t=ä. A woman with fever and cough: coronavirus disease 2019 |pdf=|usr=}}
| |
| | | |
| *'''[[Case series]]''' | | *'''[[Case series]]''' |
− | {{tp|p=32123993|t=ä. Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit |pdf=|usr=}
| |
− | {{tp|p=32092387|t=2020. Clinical features of atypical 2019 novel coronavirus pneumonia with an initially negative RT-PCR assay |pdf=|usr=}}
| |
| | | |
| | | |
− | }
| |
| *'''[[Registries]]''' | | *'''[[Registries]]''' |
| | | |
| | | |
| *'''[[Trials]]''' | | *'''[[Trials]]''' |
− | {{tp|p=32292626|t=ä. Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID) |pdf=|usr=}}
| |
− |
| |
| | | |
| *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
− | {{tp|p=32277065|t=2020. Halting coronavirus polymerase |pdf=|usr=}}
| |
− | {{tp|p=32336762|t=2012. Design of Angiotensin?converting Enzyme 2 (ACE2) Inhibitors by Virtual Lead Optimization and Screening |pdf=|usr=}}
| |
− | {{tp|p=32281318|t=2020. Convalescent Plasma Therapy for Corona Virus Disease 2019: a Long Way to Go but Worth Trying |pdf=|usr=}}
| |
− | {{tp|p=32045235|t=ä. ?-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment |pdf=|usr=}}
| |
− | {{tp|p=32105468|t=2020. Structure-Based Stabilization of Non-native Protein?Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design |pdf=|usr=}}
| |
− | {{tp|p=27905101|t=2017. (+)A review on antiviral activity of the Himalayan medicinal plants traditionally used to treat bronchitis and related symptoms |pdf=|usr=}}
| |
− | {{tp|p=16697221|t=2006. (+)Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus |pdf=|usr=}}
| |
− | {{ttp|p=31856018|t=2020. Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?|pdf=|usr=}}
| |
− | {{tp|p=32388486|t=2020. Light as a potential treatment for pandemic coronavirus infections: A perspective |pdf=|usr=}}
| |
− | {{tp|p=C7154570|t=2020. Anti-IL6R role in treatment of COVID-19-related ARDS |pdf=|usr=}}
| |
− | {{tp|p=32423584|t=2020. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial |pdf=|usr=}}
| |
− | {{tp|p=32423580|t=2020. Remdesivir for COVID-19: challenges of underpowered studies |pdf=|usr=}}
| |
| | | |
| | | |
| + | *'''[[Other routes of infection]]''' |
| | | |
| | | |
| + | *'''[[Biophysics of aerosols]]''' |
| | | |
− | *'''[[Other routes of infection]]'''
| |
− | {{tp|p=32376320|t=ä. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract |pdf=|usr=}}
| |
− | {{tp|p=32388248|t=2020. COVID-19: The environmental implications of shedding SARS-CoV-2 in human faeces |pdf=|usr=}}
| |
− | {{tp|p=32482249|t=2020. No evidence of severe acute respiratory syndrome?coronavirus 2 in semen of males recovering from coronavirus disease 2019 |pdf=|usr=}}
| |
| | | |
| | | |
− | *'''[[Biophysics of aerosols]]'''
| |
| | | |
| *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
− | {{tp|p=32278702|t=2020. Antimicrobial coating innovations to prevent infectious disease: a consensus view from the AMiCl COST Action |pdf=|usr=}}
| + | |
− | {{tp|p=32338711|t=2020. Exposure to a Surrogate Measure of Contamination From Simulated Patients by Emergency Department Personnel Wearing Personal Protective Equipment |pdf=|usr=}}
| + | |
− | {{tp|p=32404268|t=ä. 3D Printing of Face Shields During COVID-19 Pandemic: A Technical Note |pdf=|usr=}}
| + | |
− | {{tp|p=32211889|t=2020. Training and Fit Testing of Health Care Personnel for Reusable Elastomeric Half-Mask Respirators Compared With Disposable N95 Respirators |pdf=|usr=}}
| + | |
| | | |
| | | |
| *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
− | {{tp|p=32386752|t=ä. Response of Chiropractic Organizations to the COVID-19 Pandemic: A Descriptive Report |pdf=|usr=}}
| |
− | {{tp|p=C7161163|t=2020. Editorial Response to COVID-19 in Chinese neurosurgery and beyond |pdf=|usr=}}
| |
− | {{tp|p=32279098|t=ä. The virus crisis affects Orthopaedic surgery and scientific activities worldwide |pdf=|usr=}}
| |
− | {{tp|p=32268928|t=ä. Coronavirus epidemic and geriatric mental healthcare in China: how a coordinated response by professional organizations helped older adults during an unprecedented crisis |pdf=|usr=}}
| |
− | {{tp|p=32025779|t=2020. Novel coronavirus infection during the 2019?2020 epidemic: preparing intensive care units?the experience in Sichuan Province, China |pdf=|usr=}}
| |
− | {{tp|p=C7161162|t=2020. Editorial Neurosurgery in the storm of COVID-19: suggestions from the Lombardy region, Italy (ex malo bonum) |pdf=|usr=}}
| |
− | {{tp|p=32044122|t=2020. Strengthening ICU health security for a coronavirus epidemic |pdf=|usr=}}
| |
− | {{tp|p=32072300|t=ä. How to face the novel coronavirus infection during the 2019?2020 epidemic: the experience of Sichuan Provincial People?s Hospital |pdf=|usr=}}
| |
− | {{tp|p=32081700|t=2020. What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus?|pdf=|usr=}}
| |
− | {{tp|p=32283267|t=2020. Converting a Small Surgical Team into a Pandemic Response Team for an Isolated Population |pdf=|usr=}}
| |
− | {{tp|p=32303646|t=2020. Wish you were here: Meetings, no meetings, meeting reports |pdf=|usr=}}
| |
− | {{tp|p=32205660|t=ä. Novel Coronavirus and Orthopaedic Surgery: Early Experiences from Singapore |pdf=|usr=}}
| |
− | {{tp|p=32249075|t=2020. Perioperative Echocardiography: Key Considerations During the Coronavirus Pandemic |pdf=|usr=}}
| |
− | {{tp|p=32345529|t=2020. Extracorporeal Membrane Oxygenation ? Crucial Considerations during the Coronavirus Crisis |pdf=|usr=}}
| |
− | {{tp|p=32347689|t=ä. Coronavirus disease 2019 and ophthalmologists: introducing a simple protective shield for slitlamp biomicroscopic examination |pdf=|usr=}}
| |
− | {{tp|p=32367391|t=ä. Virtual House Calls: Telemedicine and Reforming the Health Care Delivery Model with Strategies Implemented in a Novel Coronavirus Pandemic |pdf=|usr=}}
| |
− | {{tp|p=32291724|t=ä. How Community and Unity Can Help Americans Survive |pdf=|usr=}}
| |
− | {{tp|p=32334945|t=2020. Donor organ evaluation in the era of coronavirus disease 2019: A case of nosocomial infection |pdf=|usr=}}
| |
− | {{tp|p=32339873|t=2020. Determination of Air Filter Anti-Viral Efficiency against an Airborne Infectious Virus |pdf=|usr=}}
| |
− | {{tp|p=32371146|t=ä. COVID-19 and Educational Engagement |pdf=|usr=}}
| |
− | {{tp|p=32302530|t=ä. The UIC COVID Coverage Protocol: A Technical Note for Pandemic Oral and Maxillofacial Surgery Call Coverage |pdf=|usr=}}
| |
− | {{tp|p=32278270|t=2020. Portable pulsed xenon ultraviolet light disinfection in a teaching hospital animal laboratory in China |pdf=|usr=}}
| |
− | {{tp|p=32360084|t=2020. Nurses in Conflict: Providing Care in Extraordinary Times |pdf=|usr=}}
| |
− | {{tp|p=32331818|t=ä. Commentary: Challenges to thoracic surgeons in the global coronavirus pandemic |pdf=|usr=}}
| |
− | {{tp|p=32289517|t=2020. Lung Cancer Surgical Management During the Outbreak of Coronavirus Disease 2019 |pdf=|usr=}}
| |
− | {{tp|p=32283315|t=ä. Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?|pdf=|usr=}}
| |
− | {{tp|p=31917025|t=2020. Society of Interventional Radiology Position Statement on the Role of Percutaneous Ablation in Renal Cell Carcinoma: Endorsed by the Canadian Association for Interventional Radiology and the Society of Interventional Oncology |pdf=|usr=}}
| |
− | {{tp|p=32360374|t=2020. Aortic Disease in the Time of COVID: Repercussions on Patient Care at an Academic Aortic Center |pdf=|usr=}}
| |
− | {{tp|p=32360373|t=ä. Vascular surgery activity condition is a common language for uncommon times |pdf=|usr=}}
| |
− | {{tp|p=32334049|t=ä. Distance learning for vascular surgeons in the era of a pandemic |pdf=|usr=}}
| |
− | {{tp|p=32334048|t=ä. Strategies and recommendations for the safe implementation of vascular surgery during the pandemic period of novel coronavirus pneumonia |pdf=|usr=}}
| |
− | {{tp|p=C7161161|t=2020. Introduction On pandemics: the impact of COVID-19 on the practice of neurosurgery |pdf=|usr=}}
| |
− | {{tp|p=32389541|t=ä. Evolution of COVID-19 Guidelines for University of Washington Oral and Maxillofacial Surgery Patient Care |pdf=|usr=}}
| |
− | {{tp|p=32202608|t=2020. Ethics Committee Reviews of Applications for Research Studies at 1 Hospital in China During the 2019 Novel Coronavirus Epidemic |pdf=|usr=}}
| |
− | {{tp|p=32387574|t=ä. Caring for Bereaved Family Members During the COVID-19 Pandemic: Before and After the Death of a Patient |pdf=|usr=}}
| |
− | {{tp|p=32387138|t=ä. COVID-19?Impact on DNR Orders in the Largest Cancer Center in Jordan |pdf=|usr=}}
| |
− | {{tp|p=32375884|t=2020. Clinical evidence based review and recommendations of aerosol generating medical procedures in otolaryngology ? head and neck surgery during the COVID-19 pandemic |pdf=|usr=}}
| |
− | {{tp|p=32376263|t=ä. Palliative Care in the Time of COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=C7141421|t=2020. Influence of Community and Culture in the Ethical Allocation of Scarce Medical Resources in a Pandemic Situation: Deliberative Democracy Study |pdf=|usr=}}
| |
− | {{tp|p=32387113|t=ä. Caring for Pediatric Patients with Diabetes amidst the Coronavirus Disease 2019 Storm |pdf=|usr=}}
| |
− | {{tp|p=32380026|t=ä. Rapid Implementation of an Adult Coronavirus Disease 2019 Unit in a Children s Hospital |pdf=|usr=}}
| |
− | {{tp|p=32381257|t=2020. Pediatric and Adolescent Gynecology (PAG) in the Time of a Pandemic |pdf=|usr=}}
| |
− | {{tp|p=32386796|t=ä. Children are at risk from COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32463074|t=ä. Impact of the Covid-19 Outbreak on the Clinical and Research Activities of Memory Clinics: An Alzheimer?s Disease Center Facing the Covid-19 Crisis |pdf=|usr=}}
| |
− | {{tp|p=C7114947|t=ä. Covid-19, Coronavirus and Mental Health Rehabilitation at Times of Crisis |pdf=|usr=}}
| |
− | {{tp|p=32417235|t=ä. Stroke priorities during COVID-19 outbreak: acting both fast and safe |pdf=|usr=}}
| |
− | {{tp|p=32467022|t=ä. Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do |pdf=|usr=}}
| |
− | {{tp|p=C7185923|t=ä. Adult Cardiac Surgery and the COVID-19 Pandemic: Aggressive Infection Mitigation Strategies are Necessary in the Operating Room and Surgical Recovery |pdf=|usr=}}
| |
− | {{tp|p=32448698|t=ä. Does nasal screening for Staphylococcus aureus before surgery compromise health care professional safety in the COVID-19 era?|pdf=|usr=}}
| |
− | {{tp|p=32387163|t=ä. Commentary: When a cardiac surgeon takes care of patients with Coronavirus Disease 2019: It?s gonna be ok!|pdf=|usr=}}
| |
− | {{tp|p=C7194800|t=ä. COVID-19: Crisis Management in Congenital Heart Surgery |pdf=|usr=}}
| |
− | {{tp|p=32448690|t=ä. Commentary: Rethinking surgical protocols in the COVID-19 era |pdf=|usr=}}
| |
− | {{tp|p=C7146695|t=ä. COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement from Thoracic Surgery Outcomes Research Network |pdf=|usr=}}
| |
− | {{tp|p=32380086|t=ä. Caring for patients with venous insufficiency during the COVID-19 pandemic at a tertiary care center |pdf=|usr=}}
| |
− | {{tp|p=C7196407|t=ä. Leveraging Interventional Radiology s Adaptability During COVID-19: A Multi-Center Single Urban Health System Experience |pdf=|usr=}}
| |
− | {{tp|p=32448761|t=ä. Endocrine surgery during and after the COVID-19 epidemic: Expert guidelines from AFCE |pdf=|usr=}}
| |
− | {{tp|p=32381427|t=ä. Pre- and post-operative screening in limited-term elective cancer surgery patients during the COVID-19 pandemic |pdf=|usr=}}
| |
− | {{tp|p=32381426|t=ä. Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery |pdf=|usr=}}
| |
− | {{tp|p=32387058|t=ä. Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic Proposals for prioritization from the RENAPE and BIG-RENAPE groups |pdf=|usr=}}
| |
− | {{tp|p=32382161|t=2020. Flexible employment relationships and careers in times of the COVID-19 pandemic |pdf=|usr=}}
| |
− | {{tp|p=32382162|t=2020. Understanding the impact of the COVID-19 pandemic on career development: Insights from cultural psychology |pdf=|usr=}}
| |
− | {{tp|p=32425006|t=ä. Efficacy of internet-based integrated intervention on depression and anxiety symptoms in patients with COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32425001|t=ä. Possible aerosol transmission of COVID-19 and special precautions in dentistry |pdf=|usr=}}
| |
− | {{tp|p=32292919|t=ä. The Novel Coronavirus Disease (COVID-19) Threat for Patients With Cardiovascular Disease and Cancer |pdf=|usr=}}
| |
− | {{tp|p=C7173805|t=ä. ?Quadruple rule out? with cardiac computed tomography in COVID-19 patient with equivocal acute coronary syndrome presentation |pdf=|usr=}}
| |
− | {{tp|p=C7196374|t=ä. TAVR during the COVID19 Pandemic: The ACC/SCAI Consensus Statement |pdf=|usr=}}
| |
− | {{tp|p=C7161496|t=ä. Role of Teleproctoring in Challenging and Innovative Structural Interventions Amidst the COVID-19 Pandemic and Beyond |pdf=|usr=}}
| |
− | {{tp|p=32425004|t=ä. Clinical value of the emergency department in screening and diagnosis of COVID-19 in China |pdf=|usr=}}
| |
− | {{tp|p=32466838|t=2020. Heart Failure Editorial Emergencies in the COVID-19 Era |pdf=|usr=}}
| |
− | {{tp|p=32451077|t=ä. (Neph)A view from the front line of the COVID-19 war |pdf=|usr=}}
| |
− | {{tp|p=32471634|t=ä. Adding insult to injury: kidney replacement therapy during COVID-19 in India |pdf=|usr=}}
| |
− | {{tp|p=32471636|t=ä. Could ferritin help the screening for COVID-19 in hemodialysis patients?|pdf=|usr=}}
| |
− | {{tp|p=32471637|t=ä. Managing the COVID-19 pandemic: international comparisons in dialysis patients |pdf=|usr=}}
| |
− | {{tp|p=C7195114|t=2020. 1-week hypofractionated adjuvant whole-breast radiotherapy: towards a new standard?|pdf=|usr=}}
| |
− | {{tp|p=C7202855|t=ä. Maintaining safety and service provision in human milk banking: a call to action in response to the COVID-19 pandemic |pdf=|usr=}}
| |
− | {{tp|p=32458805|t=2020. Promoting healthy movement behaviours among children during the COVID-19 pandemic |pdf=|usr=}}
| |
− | {{tp|p=C7200123|t=2020. COVID-19, type 1 diabetes, and technology: why paediatric patients are leading the way |pdf=|usr=}}
| |
− | {{tp|p=C7194789|t=2020. Managing diabetes in Qatar during the COVID-19 pandemic |pdf=|usr=}}
| |
− | {{tp|p=32382724|t=2020. Virtual care: new models of caring for our patients and workforce |pdf=|usr=}}
| |
− | {{tp|p=32380008|t=ä. Resumption of daily services in a gastroenterology department in Guangzhou, China, in the wake of COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32389194|t=2020. Health system quality in the time of COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32389195|t=2020. Infection prevention and control compliance in Tanzanian outpatient facilities: a cross-sectional study with implications for the control of COVID-19 |pdf=|usr=}}
| |
− |
| |
| | | |
| | | |
| *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
− | {{tp|p=32387715|t=ä. Addressing Faculty Emotional Responses during the Coronavirus 2019 Pandemic |pdf=|usr=}}
| |
| | | |
| + | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| | | |
| | | |
− | *'''[[Socio-psychiatric aspects of the status hygienicus]]'''
| |
| | | |
| | | |
| *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
− | {{tp|p=32454398|t=2020. STEMI during the COVID-19 Pandemic - An Evaluation of Incidence |pdf=|usr=}}
| + | |
− | {{tp|p=32389608|t=ä. Heart Failure in the COVID-19 Pandemic: Where has all New York s congestion gone?|pdf=|usr=}}
| + | |
| | | |
| | | |
| *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
− | {{ttp|p=32387671|t=2020. Role of the chronic air pollution levels in the Covid-19 outbreak risk in Italy? |pdf=|usr=}}
| |
− | {{tp|p=C7188145|t=ä. Reporting, Recording and Communication of COVID-19 Cases in Workplace: Data Protection as a Moving Target |pdf=|usr=}}
| |
− |
| |
| | | |
| | | |
| *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
− | {{tp|p=32287365|t=2020. The Coming Coronavirus Crisis: What Can We Learn?|pdf=|usr=}}
| |
− |
| |
| | | |
| | | |
Zeile 348: |
Zeile 145: |
| | | |
| *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
− | {{tp|p=32377932|t=ä. Animal-to-Human Viral Transitions: Is SARS-CoV-2 an Evolutionary Successful One?|pdf=|usr=}}
| |
− |
| |
− |
| |
| | | |
| *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
− | {{tp|p=C7175784|t=ä. Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2 |pdf=|usr=}}
| |
| | | |
| + | *'''[[Epidemiology]]''' |
| | | |
| | | |
− | *'''[[Epidemiology]]'''
| |
− | {{tp|p=32233163|t=2020. Understanding and Interpretation of Case Fatality Rate of Coronavirus Disease 2019 |pdf=|usr=}}
| |
− | {{tp|p=32174068|t=2020. Will the Third Wave of Coronavirus Disease 2019 Really Come in Korea?|pdf=|usr=}}
| |
− | {{tp|p=32301301|t=2020. Potential Hazards of Concern in the Walk-Through Screening System for the Corona Virus Disease 2019 from the Perspective of Infection Preventionists |pdf=|usr=}}
| |
− | {{tp|p=32270285|t=ä. An SIS model for the epidemic dynamics with two phases of the human day-to-day activity |pdf=|usr=}}
| |
− | {{tp|p=32048741|t=2020. The progress of 2019 novel coronavirus event in China |pdf=|usr=}}
| |
− | {{tp|p=32173304|t=2020. True epidemic growth construction through harmonic analysis |pdf=|usr=}}
| |
− | {{tp|p=32380045|t=2020. The COVID-19 response for vulnerable people in places affected by conflict and humanitarian crises |pdf=|usr=}}
| |
− | {{tp|p=32423582|t=2020. Preventing major outbreaks of COVID-19 in jails |pdf=|usr=}}
| |
− | {{tp|p=32423581|t=2020. Institutional, not home-based, isolation could contain the COVID-19 outbreak |pdf=|usr=}}
| |
− | {{tp|p=C7190287|t=ä. Use of the Demographic and Health Survey framework as a population surveillance strategy for COVID-19 |pdf=|usr=}}
| |
| | | |
| | | |
| | | |
| *'''[[Remission, recurrence and persistence]]''' | | *'''[[Remission, recurrence and persistence]]''' |
− | {{tp|p=32389787|t=ä. Reactivation of COVID-19 pneumonia: A report of two cases |pdf=|usr=}}
| + | |
| | | |
| | | |
Zeile 378: |
Zeile 161: |
| ---- | | ---- |
| *'''[[Failure of politics and public health guidance]]''' | | *'''[[Failure of politics and public health guidance]]''' |
− | {{tp|p=32416370|t=2020. Has COVID-19 played an unexpected ?stroke? on the chain of survival?|pdf=|usr=}}
| |
− | {{tp|p=32354343|t=2020. Evaluating the consequences of health policy decisions |pdf=|usr=}}
| |
− | {{tp|p=32380041|t=2020. COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges |pdf=|usr=}}
| |
| | | |
| | | |
Zeile 388: |
Zeile 168: |
| | | |
| *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
− | {{tp|p=32169251|t=2020. Ophthalmologists Are More Than Eye Doctors?In Memoriam Li Wenliang |pdf=|usr=}}
| |
− | {{tp|p=C7137172|t=2020. Li Wenliang |pdf=|usr=}}
| |
| | | |
| *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
Zeile 397: |
Zeile 175: |
| | | |
| *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
− | {{tp|p=32033382|t=2020. Does Wuhan Need to be in Lockdown during the Chinese Lunar New Year?|pdf=|usr=}}
| |
− | {{ttp|p=32285349|t=ä. Reflections on life in the time of the Coronavirus pandemic, from the viewpoint of two people who have experienced dialysis and kidney transplantation |pdf=|usr=}}
| |
− |
| |
| *'''[[misc.]]''' | | *'''[[misc.]]''' |
− | {{tp|p=C7188137|t=ä. Can the COVID-19 Interstate Travel Restrictions Help Lift the FDA?s Blood Ban?|pdf=|usr=}}
| + | |
− | {{tp|p=32328723|t=ä. Missed or delayed diagnosis of ARDS: a common and serious problem |pdf=|usr=}}
| + | |
− | {{tp|p=32179480|t=2020. Positive Selection of a Serine Residue in Bat IRF3 Confers Enhanced Antiviral Protection |pdf=|usr=}}
| + | *'''[[Research tools]]''' |
− | {{tp|p=32347689|t=ä. Coronavirus disease 2019 and ophthalmologists: introducing a simple protective shield for slitlamp biomicroscopic examination |pdf=|usr=}}
| + | |
− | {{tp|p=31420921|t=2019. Procalcitonin as a prognostic marker for sepsis based on SEPSIS?3 |pdf=|usr=}}
| + | |
− | {{tp|p=30577479|t=2019. Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral Infections |pdf=|usr=}}
| + | |
− | {{tp|p=28120330|t=2017. Use of an Automated Nested Multiplex Respiratory Pathogen PCR Panel Postmortem in the Pediatric Forensic Setting? |pdf=|usr=}}
| + | |
− | {{tp|p=29264071|t=2017. Risk factors for detection failures of chest radiography in diagnosing pneumonia |pdf=|usr=}}
| + | |
− | {{tp|p=16779870|t=2006. RNA interference for antiviral therapy |pdf=|usr=}}
| + | |
− | {{tp|p=32253007|t=2020. Corona Virus: Global Pandemic Causing World-Wide Shutdown |pdf=|usr=}}
| + | |
− | {{tp|p=15495266|t=2004. Cilia?related diseases |pdf=|usr=}}
| + | |
− | {{tp|p=32335777|t=ä. Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel |pdf=|usr=}}
| + | |
− | {{tp|p=32057607|t=2020. Predictors of Adolescents First Episode of Homelessness Following Substance Use Treatment |pdf=|usr=}}
| + | |
− | {{tp|p=32165077|t=2020. Social Support, Exposure to Parental Intimate Partner Violence, and Relationship Abuse Among Marginalized Youth |pdf=|usr=}}
| + | |
− | {{tp|p=C7141442|t=ä. Multi-lead QT Screening is Necessary for QT Measurement: Implications for Management of Patients in the COVID-19 Era |pdf=|usr=}}
| + | |
| | | |
| | | |
| | | |
| | | |
− | *'''[[Research tools]]''
| |
| {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} | | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| + | |
| | | |
| *'''[[PrePrint scene]]''' | | *'''[[PrePrint scene]]''' |
Zeile 427: |
Zeile 191: |
| | | |
| *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
− | *[aumbiotech.com rnai self-delivering]
| + | |
− | *[synthego.com crispr cell lines]
| + | |
| *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| *'''[[on-topic personal thoughts]]''' | | *'''[[on-topic personal thoughts]]''' |